This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Reha Technology AG Sells First G-EO System Unit In India And Opens Indian Subsidiary

OLTEN, Switzerland, November 14, 2013 /PRNewswire/ --

Reha Technology AG will be installing the first G-EO System unit in India with Dr. Zameer Jafri at the Max Balaji Super Specialty Healthcare in New Delhi and is launching direct operations in India.

Launch of Indian direct operations in New Delhi

Reha Technology AG, a Swiss company that designs, manufactures and globally distributes advanced robotic-assisted systems for neurorehabilitation, has formed an Indian subsidiary, Reha Technology India Pvt. Ltd.  The company will be operating from an office in New Delhi.

Mr. Pradeep Singh Dillon, Executive Vice President India, manages all activities for Reha Technology India Pvt. Ltd. and has established teams of specialists in sales and clinical services to intensify the active market development and to support our customers.

Mr. René Trost, CEO of Reha Technology AG, comments: "We are proud to reach another milestone in the global expansion of our company. The funding of the Indian subsidiary is strategically very important to us and was a logical step towards expanding our business in India, one of the fastest growing markets in neurorehabilitation. We are also very pleased to have Dr. Zameer Jafri-HOD at Max Balaji Super Specialty Hospital as our first customer. A bright future is ahead of us."

The G-EO Systemâ„¢

The company's G-EO System revolutionizes gait rehabilitation and improves outcomes for the patient, clinician, and the hospital with its unique feature of realistically simulating stair climbing and floor walking, as well as the ability to customize therapy for each patient.

It is the world's most advanced system for gait rehabilitation and provides the most comprehensive range of options for gait training. Short setup times, high repetition rate of exercises, and gait pattern customization are the key differentiators and make the system a unique product in the field of robotic-assisted neurorehabilitation.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs